Jennison Associates
DVAX

Jennison Associates’s Dynavax Technologies DVAX Stock Holding History

Jennison Associates’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-611,938
Closed -$15M – 684
2015
Q3 		$15M Buy
+611,938
New +$17.3M 0.02% 471

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates's DVAX Position: Q4 2015 in Review

Jennison Associates sold out of Dynavax Technologies (DVAX) in Q4 2015, closing a stake of 611,938 shares — an estimated $15M sold.

Jennison Associates first reported a position in DVAX in Q3 2015 and held it in 1 quarter. The position peaked at $15M in Q3 2015. 152 funds tracked by Wall St. Rank hold DVAX as of Q4 2015.

  • Jennison Associates reported no remaining Dynavax Technologies position as of Q4 2015 after selling out during the quarter.
  • Jennison Associates sold 611,938 Dynavax Technologies shares in Q4 2015, an estimated $15M.
  • Jennison Associates first reported a position in Dynavax Technologies in Q3 2015 and held it in 1 quarter.
  • Jennison Associates's Dynavax Technologies position peaked at $15M in Q3 2015.
  • 152 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2015.

Based on Jennison Associates's 13F filing for Q4 2015, filed 10 Feb 2016.